Lv3
300 积分 2022-05-16 加入
Abstract 1455: RLY-4008, a novel precision therapy for FGFR2-driven cancers designed to potently and selectively inhibit FGFR2 and FGFR2 resistance mutations
8小时前
求助中
F-boxing substrates away
2天前
已完结
A CRISPR activation screen identifies FBXO22 supporting targeted protein degradation
2天前
已完结
Molecular glue modulates mitochondria
3天前
已完结
The Structural Basis for Control of Eukaryotic Protein Kinases
17天前
已完结
MEK inhibitors in oncology: a patent review and update (2016 - present)
1个月前
已完结
Structural basis of RIP1 inhibition by necrostatins
2个月前
已完结
Structure-Based Drug Design of 2-Amino-[1,1′-biphenyl]-3-carboxamide Derivatives as Selective PKMYT1 Inhibitors for the Treatment of CCNE1-Amplified Breast Cancer
2个月前
已完结
MicroRNA-144-3p Represses the Growth and EMT of Thyroid Cancer via the E2F2/TNIK Axis in Cells and Male BALB/c Nude Mice
2个月前
已完结
Discovery of D6808, a Highly Selective and Potent Macrocyclic c-Met Inhibitor for Gastric Cancer Harboring MET Gene Alteration Treatment
2个月前
已完结
皖公网安备34019202002308
